Maintenance Immunosuppressive Agents as Risk Factors for BK Virus Nephropathy: A Case-Control Study

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Transplantation

• Publication date

  2009-07-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/TP.0b013e3181aa8d93PMID 19584685
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prospective monitoring of BK virus replication in renal transplant recipients

  2009cited by this paper
• Suppression of early and chronic BK polyoma virus replication by mycophenolic acid in Vero cells

  2009cited by this paper
• Epidemiology of BK Virus in Renal Allograft Recipients: Independent Risk Factors for BK Virus Replication

  2008cited by this paper
• Polyomavirus BK Versus JC Replication and Nephropathy in Renal Transplant Recipients: A Prospective Evaluation

  2007cited by this paper
• Comparison of Low Versus High Tacrolimus Levels in Kidney Transplantation: Assessment of Efficacy by Protocol Biopsies

  2007cited by this paper
• Erratum: Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction (American Journal of Transplantation (2005) 5 (582-594))

  2005cited by this paper
• Incidence of BK with Tacrolimus Versus Cyclosporine and Impact of Preemptive Immunosuppression Reduction

  2005cited by this paper
• Incidence of polyomavirus-nephropathy in renal allografts: influence of modern immunosuppressive drugs.

  2003cited by this paper
• Polyomavirus BK.

  2003cited by this paper
• Polyomavirus reactivation in native kidneys of pancreas alone allograft recipients

  2003cited by this paper
• Polyomavirus in kidney and kidney‐‐pancreas transplant recipients

  2003cited by this paper
• Clinical course of polyoma virus nephropathy in 67 renal transplant patients.

  2002cited by this paper
• Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients.

  2002cited by this paper
• Polyomavirus BK Nephropathy: A (Re‐)emerging Complication in Renal Transplantation

  2002cited by this paper
• BK virus nephropathy--polyomavirus adding insult to injury.

  2002cited by this paper
• First Clinical Use of a Novel Bioartificial Liver Support System (BLSS) †

  2002cited by this paper
• Polyomavirus in kidney and kidney-pancreas transplantation: a defined protocol for immunosuppression reduction and histologic monitoring.

  2002cited by this paper
• BK virus nephropathy diagnosis and treatment: experience at the University of Maryland Renal Transplant Program.

  2002cited by this paper
• The Epidemiology of BK Virus and the Occurrence of Antigenic and Genomic Subtypes

  2002cited by this paper
• BK virus in solid organ transplant recipients: an emerging syndrome.

  2001cited by this paper
• Differential diagnosis between infection and rejection in renal allografts.

  2001cited by this paper
• Nephropathy due to polyomavirus type BK.

  2000cited by this paper
• THE INCREASED INCIDENCE OF BK POLYOMA VIRUS IN RENAL TRANSPLANT RECIPIENTS TREATED WITH PROGRAF®.: Abstract# 1051

  2000cited by this paper
• Testing for polyomavirus type BK DNA in plasma to identify renal-allograft recipients with viral nephropathy.

  2000cited by this paper
• Polyomavirus disease under new immunosuppressive drugs: a cause of renal graft dysfunction and graft loss.

  1999cited by this paper
• Human polyoma virus in renal allograft biopsies: morphological findings and correlation with urine cytology.

  1999cited by this paper
• Polyomavirus infection of renal allograft recipients: from latent infection to manifest disease.

  1999cited by this paper
• Diagnosis and management of BK polyomavirus interstitial nephritis in renal transplant recipients.

  1999cited by this paper
• Human polyoma virus-associated interstitial nephritis in the allograft kidney.

  1999cited by this paper
• Polyomavirus-induced interstitial nephritis in two renal transplant recipients: case reports and review of the literature.

  1997cited by this paper
• Human polyoma virus infection of renal allografts: histopathologic diagnosis, clinical significance, and literature review.

  1996cited by this paper
• BK virus infection in a kidney allograft diagnosed by needle biopsy.

  1995cited by this paper
• Prospective study of the human polyomaviruses BK and JC and cytomegalovirus in renal transplant recipients.

  1984cited by this paper
• Human polyomavirus infections with JC virus and BK virus in renal transplant patients.

  1980cited by this paper
• Human polyoma virus (HPV)--a significant pathogen in renal transplantation.

  1978cited by this paper
• New human papovavirus (B.K.) isolated from urine after renal transplantation.

  1971cited by this paper
• ON THE SOURCES OF HÆMORRHAGE IN CASES OF PLACENTA PRÆVIA, &c.

  1847cited by this paper

• A systematic literature review and meta-analysis evaluated modifiable risk factors for the development of BK polyoma virus-associated complications.

  2025cites this paper
• BK Polyomavirus in Pediatric Kidney Transplant Recipients: Incidence, Risk Factors, dnDSA Development, and the Role of IVIG

  2025cites this paper
• Impact of High Tacrolimus Exposure on Graft Function and Development of a Prediction Model in Kidney Transplant Recipients: A Single-Center Retrospective Cohort Study

  2025cites this paper
• The Second International Consensus Guidelines on the Management of BK Polyomavirus in Kidney Transplantation

  2024cites this paper
• Polyomavirus Nephropathy in ABO Blood Group-Incompatible Kidney Transplantation: Torque Teno Virus and Immunosuppressive Burden as an Approximation to the Problem

  2024cites this paper
• Characteristics, risk factors and outcome of BKV nephropathy in kidney transplant recipients: a case–control study

  2023cites this paper
• Clinical Relevance of Absolute BK Polyoma Viral Load Kinetics in Patients With Biopsy Proven BK Polyomavirus Associated Nephropathy

  2022cites this paper
• Infection, Rejection, and the Connection

  2022cites this paper
• In Vitro Study Evaluating the Effect of Different Immunosuppressive Agents on Human Polyomavirus BK Replication.

  2022cites this paper
• BK Virus-Associated Nephropathy after Renal Transplantation

  2021cites this paper
• Detection of polyomavirus microRNA-5p expression in saliva shortly after kidney transplantation

  2021cites this paper
• Total nephroureterocystectomy and urethrectomy due to urothelial carcinoma associated with the BK polyomavirus infection after kidney transplantation: a case report with literature review

  2020cites this paper
• Renal Allograft Biopsies with Polyomavirus BK Nephropathy: Turin Transplant Center, 2015–19

  2020cites this paper
• Nephrotoxicity of calcineurin inhibitors as a risk factor for BK polyomavirus replication after kidney transplantation

  2020cites this paper
• Infections in Kidney and Pancreas Transplantation

  2019cites this paper
• The therapeutic effect of switching from tacrolimus to low-dose cyclosporine A in renal transplant recipients with BK virus nephropathy

  2019cites this paper
• BK viremia and nephropathy in pediatric renal transplant recipients

  2019cites this paper
• Importance of molecular diagnostic of viral infections in renal transplant recipients

  2019cites this paper
• The immunophenotyping of different stages of BK virus allograft nephropathy

  2019cites this paper
• Risk factors for BK virus viremia and nephropathy after kidney transplantation: A systematic review.

  2018cites this paper
• Incidence and outcome of BK polyomavirus infection in a multicenter randomized controlled trial with renal transplant patients receiving cyclosporine‐, mycophenolate sodium‐, or everolimus‐based low‐dose immunosuppressive therapy

  2017cites this paper
• Evaluation of the predisposition and clinical impact of BK virus replication in kidney transplant patients.

  2017cites this paper
• Ureteral stent duration and the risk of BK polyomavirus viremia or bacteriuria after kidney transplantation

  2017cites this paper
• A delicate balance between rejection and BK polyomavirus associated nephropathy; A retrospective cohort study in renal transplant recipients

  2017cites this paper
• Immunological risk assessment: The key to individualized immunosuppression after kidney transplantation.

  2016cites this paper
• Prevalence of polyoma BK virus infection among living‐donor renal transplant recipients

  2016cites this paper
• Characterization of Immunodominant BK Polyomavirus 9mer Epitope T Cell Responses

  2016cites this paper
• Outcomes of renal transplant recipients with BK virus infection and BK virus surveillance in the Auckland region from 2006 to 2012

  2016cites this paper
• BK virus nephropathy in renal transplant recipients

  2016cites this paper
• Everolimus-based immunosuppression therapy for BK virus nephropathy.

  2015cites this paper
• BK Virus Nephropathy in Kidney Transplantation: An Approach Proposal and Update on Risk Factors, Diagnosis, and Treatment.

  2015cites this paper
• Risk Factors for the Development of BK Virus Nephropathy in Renal Transplant Recipients.

  2015cites this paper
• Clinical Outcomes Associated With Induction Regimens Among Retransplant Kidney Recipients in the United States

  2015cites this paper
• ABO-incompatible kidney transplantation is a novel risk factor for BK nephropathy.

  2015cites this paper
• Risk factors for BK virus infection and BK virus-associated nephropathy under the impact of intensive monitoring and pre-emptive immunosuppression reduction.

  2014cites this paper
• BK Virus in Recipients of Kidney Transplants.

  2014cites this paper
• Pharmacology and toxicology of mycophenolate in organ transplant recipients: an update

  2014cites this paper
• Screening for BK Viremia Reduces But Does Not Eliminate the Risk of BK Nephropathy: A Single-Center Retrospective Analysis

  2013cites this paper
• Effect of maintenance immunosuppressive drugs on virus pathobiology: evidence and potential mechanisms

  2013cites this paper
• Immunophenotyping in BK Virus Allograft Nephropathy Distinct from Acute Rejection

  2013cites this paper
• BK Polyomavirus in Solid Organ Transplantation

  2013cites this paper
• Transplantation: Immunosuppression and risk of polyomavirus BK replication

  2013cites this paper
• Risk Factors for BK Virus Infection in the Era of Therapeutic Drug Monitoring

  2013cites this paper
• Clinical Manifestations of BK Virus Infection in Kidney Transplant Recipients: A Single Center Experience

  2012influential citation
• The influence of immunosuppressive agents on BK virus risk following kidney transplantation, and implications for choice of regimen.

  2012cites this paper
• Prevalence and risk factors of polyomavirus BK replication in simultaneous pancreas/kidney transplant recipients from a single transplant center

  2012cites this paper
• Factors Influencing Viral Clearing and Renal Function During Polyomavirus BK–Associated Nephropathy After Renal Transplantation

  2012cites this paper
• BK Virus Infection in Renal Allograft Recipients

  2012cites this paper
• Teaching Point (Section Editor: F.P. Schena) JC viraemia in kidney transplant recipients: to act or not to act?

  2012cites this paper
• Polyomavirus BK Replication in De Novo Kidney Transplant Patients Receiving Tacrolimus or Cyclosporine: A Prospective, Randomized, Multicenter Study

  2012cites this paper
• Management of polyomavirus-associated nephropathy in renal transplant recipients

  2012cites this paper
• Polyomanephropathie nach Nierentransplantation

  2012cites this paper
• BK virus replication following kidney transplant: does the choice of immunosuppressive regimen influence outcomes?

  2012cites this paper
• Polyomavirus nephropathy – recent pathological diagnostic problems and the report from the 2011 Banff meeting

  2012cites this paper
• Polyomavirus BK Replication in De Novo Kidney Transplant Patients Receiving Tacrolimus or Cyclosporine : A Prospective , Randomized , Multicenter Study

  2012cites this paper
• The BK virus in renal transplant recipients—review of pathogenesis, diagnosis, and treatment

  2011cites this paper
• Individualized dosing of calcineurin inhibitors in renal transplantation

  2011cites this paper
• Mammalian target of rapamycin signal inhibitors could play a role in the treatment of BK polyomavirus nephritis in renal allograft recipients

  2011cites this paper
• Intensive polyoma virus nephropathy treatment as a preferable approach for graft surveillance.

  2011cites this paper
• BK Virus in Kidney Transplant Recipients: The Influence of Immunosuppression

  2011cites this paper
• Viral impact on long-term kidney graft function.

  2010cites this paper
• Immunosuppressive agents as risk factors for BK virus nephropathy: an overview and update

  2010cites this paper
• Maintenance immunosuppressive agents as risk factors for BK virus nephropathy: the need for true drug exposure measurements.

  2010cites this paper
• Authorsʼ Reply to Maintenance Immunosuppressive Agents as Risk Factors for BK Virus Nephropathy

  2010cites this paper
• First documented case of BK nephropathy in kidney transplant recipient in Croatia: usage of urine cytology in evaluation process.

  2010cites this paper
• Reducing Immunosuppression Preserves Allograft Function in Presumptive and Definitive Polyomavirus‐Associated Nephropathy

  2010cites this paper
• Surveillance and Modification of Immunosuppression Minimizes BK Virus Nephropathy

  2010cites this paper
• BK Virus in Solid Organ Transplant Recipients

  2009cites this paper
• Transcriptional Regulation of BK Virus by Nuclear Factor of Activated T Cells

  2009cites this paper
• International Journal of Organ Transplantation Medicine Incidence of Bk Virus Nephropathy (bkvn) in Renal Transplant Recipients

  year unknowncites this paper